<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1485">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05141825</url>
  </required_header>
  <id_info>
    <org_study_id>SPHIC-TR-CERC-2021-01</org_study_id>
    <nct_id>NCT05141825</nct_id>
  </id_info>
  <brief_title>Proton and Carbon Ion Radiotherapy for Cervical Cancer</brief_title>
  <official_title>Proton and Carbon Ion Radiotherapy for Cervical Cancer : A Retrospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Proton and Heavy Ion Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Proton and Heavy Ion Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the toxicity and tolerance of proton and carbon ion&#xD;
      radiotherapy (PCRT) for cervical cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To retrospectively analyze cervical cancer patients received radical proton and carbon&#xD;
      radiotherapy in our center. The acute and late toxicities, overall survival (OS), local&#xD;
      control rate (LC), progression-free survival (PFS) and distant metastasis-free survival&#xD;
      (DMFS) were analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">October 31, 2021</completion_date>
  <primary_completion_date type="Actual">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival rate</measure>
    <time_frame>3 years</time_frame>
    <description>overall survival rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local control rate</measure>
    <time_frame>3 years</time_frame>
    <description>local control rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression-free survival</measure>
    <time_frame>3 years</time_frame>
    <description>progression-free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distant metastasis-free survival</measure>
    <time_frame>3 years</time_frame>
    <description>distant metastasis-free survival</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>proton and carbon ion radiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>proton and carbon ion radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>proton and carbon ion radiotherapy</intervention_name>
    <description>proton and carbon ion radiotherapy</description>
    <arm_group_label>proton and carbon ion radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. . histologically diagnosis of squamous cell carcinoma of the cervix;&#xD;
&#xD;
          2. . International Federation of Gynecology and Obstetrics (FIGO) stage (2014) IB2 -&#xD;
             IIIB, without rectum invasion; or FIGO stage IA - IB1, who refused surgery or were&#xD;
             contraindication for surgery due to comorbidity diseases;&#xD;
&#xD;
          3. . received proton and carbon ion radiotherapy (PCRT) with or without chemotherapy for&#xD;
             curative intention;&#xD;
&#xD;
          4. . Follow-up data available.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. a previous history of other malignancy;&#xD;
&#xD;
          2. squamous cell carcinoma of the cervix patients who had received surgery;&#xD;
&#xD;
          3. rectum was invaded.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qing Zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Proton and Heavy Ion Center</affiliation>
  </overall_official>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 23, 2021</study_first_submitted>
  <study_first_submitted_qc>November 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Proton and Heavy Ion Center</investigator_affiliation>
    <investigator_full_name>Zhan Yu</investigator_full_name>
    <investigator_title>physician of abdorminal and pelvic oncology department</investigator_title>
  </responsible_party>
  <keyword>proton and carbon ion radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

